Literature DB >> 26211456

Evaluation of bone mass in children and young adults with juvenile idiopathic arthritis.

Tingting Tang1, Xuemei Tang1, Li Xu1, Yingbo Huang1, Jie Zeng1, Qiu Li1.   

Abstract

OBJECTIVES: To examine bone mineral density (BMD) in the spines of patients with juvenile idiopathic arthritis (JIA), and to identify the main predictors of spine BMD.
METHODS: 160 patients with JIA (82 female, 78 male; median age, 8.7±3.9 years (range, 2.2-18.2 years)) who fulfilled the International League of Associations for Rheumatology (ILAR) criteria were enrolled. All subjects underwent an initial dual energy x-ray absorptiometry (DXA) scan of the lumbar spine, while 114 and 87 patients underwent a second and third scan, respectively. The data were compared with those obtained for 114 sex- and age-matched healthy controls.
RESULTS: The DXA scans revealed that the JIA patients had a significant spine BMD deficit compared with control subjects (p<0.001). Longitudinal comparison of patients revealed no significant short-term improvement in the spine BMD. Spine BMD correlated with the age (p<0.05), subtype (p<0.05), and disease activity (p<0.01), BMI (p=0.001), glucocorticoid (GC) exposure (p< 0.05), methotrexate (MTX) therapy (p<0.05), and non-steroidal anti-inflammatory agents (NSAIDs) (p<0.05), erythrocyte sedimentation rate (ESR) (p<0.01), and C-reactive protein (CRP) levels (p<0.01).
CONCLUSIONS: Patients with JIA have low bone mass, especially those in the polyarticular group >7 years old with higher disease activity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26211456

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  5 in total

Review 1.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

2.  Adjunctive vitamin D for the treatment of active juvenile idiopathic arthritis: An open-label, prospective, randomized controlled trial.

Authors:  Tao Tang; Yu Zhang; Chong Luo; Mingyue Liu; Li Xu; Xuemei Tang
Journal:  Exp Ther Med       Date:  2019-10-25       Impact factor: 2.447

3.  A 2-year longitudinal study of bone health in adolescent patients with axial spondyloarthritis.

Authors:  Shin-Hee Kim; Ki Hwan Kim; Moon-Young Kim; Yeon Sik Hong; Kwi Young Kang
Journal:  Arch Osteoporos       Date:  2021-01-08       Impact factor: 2.617

4.  No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis.

Authors:  P C E Hissink Muller; W G van Braak; D Schreurs; C M Nusman; S A Bergstra; R Hemke; D Schonenberg-Meinema; J M van den Berg; T W Kuijpers; Y Koopman-Keemink; M A J van Rossum; L W A van Suijlekom-Smit; D M C Brinkman; C F Allaart; R Ten Cate; M Maas
Journal:  Pediatr Rheumatol Online J       Date:  2019-09-04       Impact factor: 3.054

5.  A wearable activity tracker intervention for promoting physical activity in adolescents with juvenile idiopathic arthritis: a pilot study.

Authors:  Liane D Heale; Saunya Dover; Y Ingrid Goh; Victoria A Maksymiuk; Greg D Wells; Brian M Feldman
Journal:  Pediatr Rheumatol Online J       Date:  2018-10-22       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.